Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chonnam Medical Journal ; : 75-81, 2014.
Artigo em Inglês | WPRIM | ID: wpr-42139

RESUMO

The association of postmenopausal osteoporosis (PMOP) with both atherosclerosis and vascular/valvular calcification is well known. Recently, ample evidence has suggested a common etiologic factor, namely, reduced HDL-associated paraoxonase 1 (PON1) activity, as a causative factor in the development of PMOP and cardiovascular disease (CVD). This common etiologic factor not only contributes to atherosclerotic diseases but also to PMOP following an almost identical mechanism including dysfunctional HDL and lipid oxidation. According to recent studies, lipid oxidation might improve osteoblastic transformation of vascular cells and obstruct such transformation in bone cells. The primary objective of this current review was to summarize the evidence revealing the role of HDL-associated PON1 enzyme in PMOP. Additionally, the review aimed to address some of the subjects that need further investigation in order to define whether hyperhomocysteinemia and sensitivity to lipid oxidation may be risk factors for PMOP.


Assuntos
Feminino , Humanos , Arildialquilfosfatase , Aterosclerose , Doenças Cardiovasculares , Hiper-Homocisteinemia , Menopausa , Osteoblastos , Osteoporose , Osteoporose Pós-Menopausa , Estresse Oxidativo , Fatores de Risco
2.
Chonnam Medical Journal ; : 75-81, 2014.
Artigo em Inglês | WPRIM | ID: wpr-788299

RESUMO

The association of postmenopausal osteoporosis (PMOP) with both atherosclerosis and vascular/valvular calcification is well known. Recently, ample evidence has suggested a common etiologic factor, namely, reduced HDL-associated paraoxonase 1 (PON1) activity, as a causative factor in the development of PMOP and cardiovascular disease (CVD). This common etiologic factor not only contributes to atherosclerotic diseases but also to PMOP following an almost identical mechanism including dysfunctional HDL and lipid oxidation. According to recent studies, lipid oxidation might improve osteoblastic transformation of vascular cells and obstruct such transformation in bone cells. The primary objective of this current review was to summarize the evidence revealing the role of HDL-associated PON1 enzyme in PMOP. Additionally, the review aimed to address some of the subjects that need further investigation in order to define whether hyperhomocysteinemia and sensitivity to lipid oxidation may be risk factors for PMOP.


Assuntos
Feminino , Humanos , Arildialquilfosfatase , Aterosclerose , Doenças Cardiovasculares , Hiper-Homocisteinemia , Menopausa , Osteoblastos , Osteoporose , Osteoporose Pós-Menopausa , Estresse Oxidativo , Fatores de Risco
3.
Gut and Liver ; : 675-680, 2013.
Artigo em Inglês | WPRIM | ID: wpr-209559

RESUMO

BACKGROUND/AIMS: An impaired oxidative/antioxidative status plays an important role in the pathogenesis of many diseases, including cancer. The aim of this study was to evaluate the levels of the novel marker ischemia-modified albumin (IMA) and albumin-adjusted IMA (Adj-IMA) in patients with colorectal cancer (CRC) and look for the associations of these with the total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI). METHODS: Forty patients with CRC (19 females and 21 males; mean age, 56.5+/-2.1 years) and 39 age- and sex-matched healthy people (22 females and 17 males; mean age, 56.0+/-1.7 years) were included in this study. Serum levels of IMA, TAS, and TOS were analyzed, and the OSI was calculated. RESULTS: Serum IMA, TOS, and OSI levels were significantly higher in patients with CRC than in controls (p<0.0001), whereas TAS levels were significantly lower in CRC patients (p=0.03). There was no significant difference in serum Adj-IMA levels between groups (p=0.32). CONCLUSIONS: In this study, the oxidative/antioxidant status was impaired in favor of oxidative stress in CRC patients. This observation was not confirmed by IMA measurement. Further studies are needed to establish the relationship between IMA and oxidative stress parameters in CRC and other cancers.


Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Antioxidantes/metabolismo , Biomarcadores/sangue , Estudos de Casos e Controles , Neoplasias Colorretais/sangue , Oxidantes/sangue , Estresse Oxidativo , Estudos Prospectivos , Albumina Sérica/metabolismo , Biomarcadores Tumorais/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA